Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.

Wu J, Huang S, Zhao X, Chen M, Lin Y, Xia Y, Sun C, Yang X, Wang J, Guo Y, Song J, Zhang E, Wang B, Zheng X, Schlaak JF, Lu M, Yang D.

J Virol. 2014 Sep;88(18):10421-31. doi: 10.1128/JVI.00996-14. Epub 2014 Jun 11.

2.

Delivery of host cell-directed therapeutics for intracellular pathogen clearance.

Collier MA, Gallovic MD, Peine KJ, Duong AD, Bachelder EM, Gunn JS, Schlesinger LS, Ainslie KM.

Expert Rev Anti Infect Ther. 2013 Nov;11(11):1225-35. doi: 10.1586/14787210.2013.845524. Epub 2013 Oct 18. Review.

3.

Updates on clinical pharmacology of dengue.

Wiwanitkit V.

Indian J Pharmacol. 2013 Jan-Feb;45(1):105. doi: 10.4103/0253-7613.106452. No abstract available.

4.
5.

C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection.

Julander JG, Skirpstunas R, Siddharthan V, Shafer K, Hoopes JD, Smee DF, Morrey JD.

Antiviral Res. 2008 Jun;78(3):230-41. doi: 10.1016/j.antiviral.2008.01.007. Epub 2008 Feb 13.

6.

Sensing of viral infection and activation of innate immunity by toll-like receptor 3.

Vercammen E, Staal J, Beyaert R.

Clin Microbiol Rev. 2008 Jan;21(1):13-25. doi: 10.1128/CMR.00022-07. Review.

7.

Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.

Jin B, Wang RY, Qiu Q, Sugauchi F, Grandinetti T, Alter HJ, Shih JW.

Immunology. 2007 Sep;122(1):15-27. Epub 2007 Apr 23.

8.

Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model.

Julander JG, Siddharthan V, Blatt LM, Schafer K, Sidwell RW, Morrey JD.

Virology. 2007 Apr 10;360(2):454-60. Epub 2006 Nov 21.

Items per page

Supplemental Content

Write to the Help Desk